Picture of Alimera Sciences logo

ALIM — Alimera Sciences News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapMomentum Trap

Alimera Sciences Inc reports results for the quarter ended in September - Earnings Summary

* Alimera Sciences Inc  ALIM.OQ  reported a quarterly
adjusted
loss of 75 cents​​ per share for the quarter ended in September.
The mean expectation of three analysts for the quarter was for a
loss of 40 cents per share.
    * Revenue rose 11.9% to $13.60 million from a year ago;
analysts
expected $15.17 million. 
    * Alimera Sciences Inc's reported EPS for the quarter was a
loss
of 75 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Alimera Sciences Inc shares had fallen by 2.0% this
quarter and
lost 2.9% so far this year.
    * The company reported a quarterly loss of $5.26 million.
    * Wall Street's median 12-month price target for Alimera
Sciences
Inc is $11.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
14 at 02:30 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.40          -0.75          Missed
 Jun. 30 2022      -0.55          -0.45          Beat
 Mar. 31 2022      -0.69          -0.85          Missed
 Dec. 31 2021      -0.42          -0.59          Missed

Recent news on Alimera Sciences

See all news